Novartis returns to sales growth as cancer and MS drugs offset Entresto's steep declinePharmaBy Colleen Cabili
3M beat earnings expectations and raised its full-year forecast — its stock surgedBusiness NewsBy Colleen Cabili
Samsung is launching its first U.S. credit card with rewards tied to its own devicesRetailBy Cris Tolomia
Kraft Heinz is striking a multiyear deal with Disney to supply its resorts and put characters on its productsFoodBy Cris Tolomia
Tempus AI is acquiring cancer-monitoring firm Personalis in a $1.5 billion stock dealPharmaBy Cris Tolomia
Hasbro raised its full-year outlook after a record quarter for Magic: The GatheringRetailBy Cris Tolomia
Abu Dhabi's national oil company is committing $6.2 billion to a massive offshore gas fieldBusiness NewsBy Cris Tolomia
Novo Nordisk is suing Eli Lilly over ads it says mislead consumers on weight loss drug efficacyPharmaBy Cris Tolomia
General Motors beat earnings expectations and raised its full-year profit outlookAutosBy Cris Tolomia
Trump is slapping Canada with 50% tariffs over autos, alcohol, and dairy disputesPolitics & GovernmentBy Cris Tolomia
